Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis
Texas settles another opioid lawsuit, wins $225 million against Teva
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals will pay $420 million in a federal case
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva agrees to $4.25 billion settlement in opioid lawsuit
Drug Companies Teva, Allergan Ready to Pay $5 Billion to Resolve Opioid Suits - Bloomberg
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy
Setback for Teva as court dismisses Copaxone lawsuit - PMLiVE
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | KTLA
Opioid Lawsuit Against Teva Pharma
DOJ accuses drugmaker Teva of illegal kickbacks to inflate prices | Fox Business
Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
